S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW

BACKGROUND: Millions of people use antipsychotic medications. Thousands of clinicians (often non-psychiatrists) prescribe and monitor them every day. Existing research reports mostly favorable risk-benefit ratio during the first years of schizophrenia, but their risk-benefit ratio and maintenance ef...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Schizophr Bull
Asıl Yazarlar: Isohanni, Matti, Miettunen, Jouko, Jääskeläinen, Erika, Moilanen, Jani, Hulkko, Anja, Huhtaniska, Sanna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888038/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby018.1017
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller